RegisterLogin

Oritavancin diphosphate

CAT: 0026-B2713-5Size: 5 mgDry Ice: NoHazardous: No
CAT#:0026-B2713-5Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Oritavancin diphosphate is a second-generation, semi-synthetic lipoglycopeptide, that is derived from chloroeremomycin, an analogue of vancomycin. Similar to vancomycin, it contains a core heptapeptide; however, its unique lipophilic side chain provides oritavancin with a prolonged half-life compared to the parent drug. Oritavancin has a multifaceted mechanism of action that displays concentration-dependent effects against gram-positive organisms. Similar to vancomcyin and other glycopeptides, oritavancin inhibits cell wall biosynthesis by binding noncovalently to the D-alanyl-D-alanine terminal ends of the peptidoglycan chain and pentaglycine bridge, thereby inhibiting transglycosylation and transpeptidation.
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months

Related Products

CatalogName
1825-100Chloroquine Diphosphate
B2196-25Motesanib diphosphate
B2196-5Motesanib diphosphate
1825-500Chloroquine Diphosphate
2893-25LDE-225 diphosphate
2893-5LDE-225 diphosphate

Alternative Products

CatalogName
O032-10MGOritavancin Diphosphate
HY-B1831A-01Oritavancin (diphosphate)
MBS575620Oritavancin diphosphate
HY-B1831AR-01Oritavancin (diphosphate) (Standard)
RM-O182000-01Oritavancin
MBS385097-01Oritavancin (LY333328)
A15771-5Oritavancin 5mg
TRC-O675050-1MGOritavancin Phosphate
A15771-2Oritavancin 2mg
75010ComASO Oritavancin

Popular Products